MARAMAI, SAMUELE
 Distribuzione geografica
Continente #
EU - Europa 3.089
NA - Nord America 2.903
AS - Asia 1.842
SA - Sud America 310
AF - Africa 92
OC - Oceania 3
Totale 8.239
Nazione #
US - Stati Uniti d'America 2.838
IT - Italia 761
RU - Federazione Russa 654
CN - Cina 555
SG - Singapore 536
GB - Regno Unito 521
IE - Irlanda 264
BR - Brasile 243
DE - Germania 240
VN - Vietnam 215
HK - Hong Kong 157
SE - Svezia 136
FR - Francia 135
FI - Finlandia 130
KR - Corea 116
UA - Ucraina 98
IN - India 90
ZA - Sudafrica 48
TR - Turchia 37
CA - Canada 33
ES - Italia 30
AR - Argentina 28
JP - Giappone 25
MX - Messico 24
NL - Olanda 22
AT - Austria 21
PL - Polonia 18
BD - Bangladesh 16
IQ - Iraq 16
EC - Ecuador 15
ID - Indonesia 13
PK - Pakistan 12
BE - Belgio 10
CZ - Repubblica Ceca 10
EG - Egitto 10
NG - Nigeria 9
CO - Colombia 8
JO - Giordania 7
CI - Costa d'Avorio 6
IR - Iran 6
SA - Arabia Saudita 6
KE - Kenya 5
LT - Lituania 5
CL - Cile 4
HU - Ungheria 4
IL - Israele 4
MA - Marocco 4
NP - Nepal 4
PT - Portogallo 4
RO - Romania 4
RS - Serbia 4
AZ - Azerbaigian 3
CH - Svizzera 3
EE - Estonia 3
JM - Giamaica 3
TN - Tunisia 3
UZ - Uzbekistan 3
AM - Armenia 2
AU - Australia 2
BO - Bolivia 2
CG - Congo 2
CR - Costa Rica 2
GY - Guiana 2
HR - Croazia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LV - Lettonia 2
PE - Perù 2
PS - Palestinian Territory 2
PY - Paraguay 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
HN - Honduras 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
SI - Slovenia 1
SN - Senegal 1
SR - Suriname 1
TH - Thailandia 1
Totale 8.236
Città #
Dallas 534
Southend 435
Singapore 335
Dublin 261
Fairfield 213
Ashburn 203
Siena 202
Moscow 164
Hefei 161
San Jose 152
Chandler 150
Hong Kong 147
Santa Clara 140
Munich 121
Seoul 114
Milan 109
Beijing 103
Woodbridge 97
Wilmington 91
Helsinki 90
Seattle 89
Florence 85
Ann Arbor 81
Houston 80
Jacksonville 74
Los Angeles 71
Cambridge 68
Hanoi 61
New York 60
Ho Chi Minh City 54
Council Bluffs 44
Johannesburg 44
The Dalles 42
Lauterbourg 39
Bengaluru 35
Princeton 33
Shanghai 30
Nanjing 27
Izmir 26
Dearborn 25
Rome 25
Boardman 23
Tokyo 23
São Paulo 20
Buffalo 19
San Diego 17
London 16
Frankfurt am Main 15
Orem 15
Vienna 15
Amsterdam 14
Da Nang 13
Lappeenranta 13
Warsaw 13
Bari 12
Chicago 12
Columbus 12
Fremont 12
Nuremberg 12
Rio de Janeiro 12
Redondo Beach 11
Toronto 11
Washington 11
Chennai 10
Düsseldorf 10
Guangzhou 10
Haiphong 10
Parma 10
San Mateo 10
Turku 10
Abuja 9
Brooklyn 9
Brussels 9
L’Aquila 9
Mexico City 9
Mogliano 9
Naples 9
Salt Lake City 9
Brno 8
Guayaquil 8
San Francisco 8
Aligarh 7
Boston 7
Cairo 7
Lancaster 7
Montreal 7
Málaga 7
Nanchang 7
Palermo 7
Stockholm 7
Abidjan 6
Amman 6
Baghdad 6
Belo Horizonte 6
Bologna 6
Changsha 6
Charlotte 6
Jakarta 6
Jiaxing 6
Jinan 6
Totale 5.525
Nome #
(S)-2-Amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)propanoic Acid (AMPA) and Kainate Receptor Ligands: further exploration of bioisosteric replacements and structural and biological investigation 435
Development of novel cyclic peptides as pro-apoptotic agents 385
Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain 374
Novel analgesic/anti-inflammatory agents: 1,5-Diarylpyrrole nitrooxyethyl sulfides and related compounds as Cyclooxygenase-2 inhibitors containing a nitric oxide donor moiety endowed with vasorelaxant properties 327
Activation of the Wnt pathway by small peptides: rational design, synthesis and biological evaluation 325
Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic Pain 311
A stereoselective approach to peptidomimetic BACE1 inhibitors 290
Dopamine D3 receptor antagonists as potential therapeutics for the treatment of neurological diseases 274
Harnessing the role of HDAC6 in Idiopathic Pulmonary Fibrosis: design, synthesis, structural analysis, and biological evaluation of potent inhibitors 272
Design, synthesis and biological evaluation of light-driven on-off multitarget AChE and MAO-B inhibitors 270
Discovery of Potent Inhibitors of Human and Mouse Fatty Acid Amide Hydrolases 263
Selective Kainate Receptor (GluK1) Ligands Structurally Based upon 1H-Cyclopentapyrimidin-2,4(1H,3H)-dione: Synthesis, Molecular Modeling, and Pharmacological and Biostructural Characterization 234
Disease modifying anti-Alzheimer’s drugs: inhibitors of human cholinesterases interfering with β-amyloid aggregation 231
Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition properties 213
2-Hydroxy-5-(3,5,7-trihydroxy-4-oxo-4H-chromen-2-yl)phenyl(E)-3-(4-hydroxy-3-methoxyphenyl)acrylate: synthesis, in silico analysis and in vitro pharmacological evaluation 213
In Silico-Guided Rational Drug Design and Synthesis of Novel 4-(Thiophen-2-yl)butanamides as Potent and Selective TRPV1 Agonists 210
Multifunctional Cholinesterase and Amyloid Beta Fibrillization Modulators. Synthesis and Biological Investigation 205
Harnessing the pyrroloquinoxaline scaffold for FAAH and MAGL interaction: definition of the structural determinants for enzyme inhibition 205
An Intramolecular Hydroaminomethylation-Based Approach to Pyrrolizidine Alkaloids under Microwave-Assisted Heating 199
Novel multitarget directed ligands inspired by riluzole: A serendipitous synthesis of substituted benzo[b][1,4]thiazepines potentially useful as neuroprotective agents 189
Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. SARs, Structural Analysis, and Biological Characterization 181
Catechol-O-methyltransferase (COMT) 180
Light-mediated activation/deactivation control and in vitro ADME-Tox profiling of a donepezil-like Dual AChE/MAO-B Inhibitor 176
Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studies 176
Quinolines and Oxazino-quinoline derivatives as small molecule GLI1 inhibitors identified by virtual screening 168
Exploiting the bile acid binding protein as transporter of a Cholic Acid/Mirin bioconjugate for potential applications in liver cancer therapy 162
Use of imidazo[1,5-a]quinoline scaffold as the pharmacophore in the design of bivalent ligands of central benzodiazepine receptors 157
Lipoic/Capsaicin-Related Amides: Synthesis and Biological Characterization of New TRPV1 Agonists Endowed with Protective Properties against Oxidative Stress 155
Micellar catalysis for sustainable hydroformylation 155
Development of a practical and scalable route for the preparation of the deacetoxytubuvaline (dTuv) fragment of pretubulysin and analogs 151
Structural characterization of human heat shock protein 90 N-Terminal domain and its variants K112R and K112A in complex with a potent 1,2,3-Triazole-based inhibitor 148
CHAPTER 18: Microwave Irradiation 144
Subtype selective γ-Aminobutyric scid type A receptor (GABAAR) modulators acting at the benzodiazepine binding site: an update 136
Indole-2-Carboxamide as an Effective Scaffold for the Design of New TRPV1 Agonists 134
Macroreticular POLITAG-Pd(0) for the waste minimized hydrogenation/reductive amination of phenols using formic acid as hydrogen source 122
null 109
Inhibition of monoacylglycerol lipase by NSD1819 as an effective strategy for the endocannabinoid system modulation against neuroinflammation-related disorders 96
Multitarget therapeutic strategies for Alzheimer's disease: review on emerging target combinations 87
Therapeutic potential for coxib-nitric oxide releasing hybrids in cancer treatment 71
Multitarget-directed ligands for neurodegenerative diseases: real opportunity or blurry mirage? 67
Targeting endocannabinoid metabolism: an arrow with multiple tips against multiple sclerosis 54
VA1213, a selective COX-2 inhibitor, exhibits antitumor activity by suppressing EGFR, AKT, and ERK1/2 phosphorylation 52
Drug enteric metabolism in gut microbiota-brain crosstalk 47
Evaluation of a New Riluzole‐Based Compound VA945 on Sodium and Potassium Conductances Expressed by SH-SY5Y-Derived Neurons 45
Totale 8.398
Categoria #
all - tutte 22.592
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.592


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021134 0 0 0 0 0 0 0 0 0 83 31 20
2021/2022439 39 48 44 45 16 15 31 21 20 45 48 67
2022/2023587 23 43 74 72 72 122 28 54 62 18 12 7
2023/2024670 50 24 70 42 49 135 150 10 11 23 22 84
2024/20251.560 61 51 149 95 140 98 130 103 142 86 134 371
2025/20263.471 299 520 463 490 615 145 456 143 148 192 0 0
Totale 8.398